Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2025)

Arcus Biosciences (RCUS) has 8 years of Interest & Investment Income data on record, last reported at $1.0 million in Q4 2025.

  • For Q4 2025, Interest & Investment Income changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $35.0 million, changed N/A, while the annual FY2025 figure was $41.0 million, 21.15% down from the prior year.
  • Interest & Investment Income reached $1.0 million in Q4 2025 per RCUS's latest filing, down from $10.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $13.0 million in Q1 2024 and bottomed at $154000.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $6.2 million, with a median of $7.4 million recorded in 2022.
  • Peak YoY movement for Interest & Investment Income: tumbled 76.2% in 2021, then soared 3005.59% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $519000.0 in 2021, then surged by 1329.29% to $7.4 million in 2022, then soared by 48.29% to $11.0 million in 2023, then increased by 18.18% to $13.0 million in 2024, then tumbled by 92.31% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $1.0 million in Q4 2025, $10.0 million in Q3 2025, and $11.0 million in Q1 2025.